Belmopan. November 20th, 2012. Earlier this year, reports were made to the Ministry of Health concerning the sale of a pharmaceutical product being marketed as “TLEMOL.”
The Ministry sent the product for testing shortly after. This week we received a Certificate of Analysis from the Caribbean Regional Drug Testing Laboratory in Kingston, Jamaica concluding that the pharmaceutical product marketed as ‘Tlemol’ has met the United States Pharmaceutical requirements for Acetaminophen tablets.
The Ministry of Health assures the public that the active ingredient in this product “TLEMOL” is acetaminophen 500mg, which is the same ingredient in the similar product, TYLENOL.
As stated in our initial release, preliminary investigations revealed that Tlemol is marketed in the United States of America under this name and it was legally imported in Belize by the company, Generic Club Ltd and duly registered by the Belize Intellectual Property Office (BELIPO.)
For More Information contact:
Ministry of Health
88-2325 / 2363